Mechanisms underpinning antipsychotic drug sensitivity in Alzheimer's disease

被引：1
|
作者：
Reeves, S. [1 ]
机构：
[1] Inst Psychiat, Old Age, Camberwell London, England
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2015年 / 25卷
关键词：
D O I：
10.1016/S0924-977X(15)30821-X
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.5.b.007
引用
收藏
页码：S584 / S585
页数：2
相关论文
共 50 条
  • [1] Risk of antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
    Suh, DC
    Arcona, S
    Thomas, SK
    Powers, C
    Rabinowicz, AL
    Shin, HC
    Mirski, D
    [J]. DRUGS & AGING, 2004, 21 (06) : 395 - 403
  • [2] Risk of Antipsychotic Drug Use in Patients with Alzheimer’s Disease Treated with Rivastigmine
    Dong-Churl Suh
    Stephen Arcona
    Simu K. Thomas
    Christopher Powers
    Adrian L. Rabinowicz
    Hyunchul Shin
    Dario Mirski
    [J]. Drugs & Aging, 2004, 21 : 395 - 403
  • [3] Alzheimer's Disease - Mechanisms, Drug Targets and Alternative Treatments
    Hua, Qian
    He, Rongqiao
    [J]. CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (05) : 470 - 471
  • [4] Impact of rivastigmine on time to first antipsychotic drug use in patients with Alzheimer's disease
    Suh, DC
    Arcona, S
    Thomas, S
    Chang, S
    Powers, C
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 271 - 272
  • [5] Atypical antipsychotic drugs and Alzheimer's disease
    Jockers-Scheruebl, Maria C.
    Hellweg, Rainer
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (04): : 416 - 417
  • [6] Neurotoxicity of antipsychotic drugs in Alzheimer's disease
    Bonelli, RM
    Aschoff, A
    Niederwieser, G
    Heuberger, C
    Jirikowski, G
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2002, 12 : S366 - S367
  • [7] Is antipsychotic sensitivity in Alzheimer's disease secondary to abnormal blood-brain barrier integrity?
    Caravaggio, Fernando
    Graff-Guerrero, Ariel
    [J]. BRAIN, 2017, 140 : 865 - 867
  • [8] MECHANISMS OF DISEASE Alzheimer's Disease
    Querfurth, Henry W.
    LaFerla, Frank M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (04): : 329 - 344
  • [9] Decreased risk of first antipsychotic drug use in patients with Alzheimer's disease treated with rivastigmine
    Suh, DC
    Arcona, S
    Thomas, SK
    Powers, C
    Rabinowicz, A
    Mirski, D
    [J]. INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 325 - 325
  • [10] In silico repurposing of antipsychotic drugs for Alzheimer’s disease
    Shivani Kumar
    Suman Chowdhury
    Suresh Kumar
    [J]. BMC Neuroscience, 18
12345